InnoCare Pharma eyes Hong Kong listing
Chinese firm InnoCare Pharma is looking for permission to list in Hong Kong, having filed a draft IPO prospectus with the city’s stock exchange.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: